2014-02-20 – China Stock Advice

MONT [MONTAGE TECHNOLOGY] 8-K: Montage Technology Reports Fourth Quarter and Fiscal 2013

[Montage Technology Reports Fourth Quarter and Fiscal 2013 Financial Results Fourth Quarter Revenue Increases 17.9% Sequentially and 49.5% Year-Over-Year to $35.4 Million; Gross Margin was 62.4% and Operating Margin 25.1% SHANGHAI, China February 20, 2014 Fourth Quarter 2013 Highlights: Attained record revenue of $35.4 million, an increase of 17.9 percent sequentially and 49.5 percent year-over-year; Reported 62.4] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1]

By info| 2016-03-20T02:10:29+00:00 February 20th, 2014|Categories: Chinese Stocks, MONT, Webplus ver|Tags: 0001375514, 2014-02-20, 3674, 8-K, MONT, SEMICONDUCTORS and RELATED DEVICES|0 Comments

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)

[This Form 6-K consists of: th th An announcement regarding resolutions of the 14 CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) ANNOUNCEMENT ON THE RESOLUTIONS OF THE FOURTEENTH MEETING OF THE FIFTH SESSION OF THE BOARD OF DIRECTORS Proposal to Start the Restructuring of]

By info| 2016-03-23T08:47:35+00:00 February 20th, 2014|Categories: Chinese Stocks, SEC Original, SNP|Tags: 0001123658, 2014-02-20, 2911, 6-K, PETROLEUM REFINING, SNP|0 Comments

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: This Form 6-K consists of: th th An

[This Form 6-K consists of: th th An announcement regarding resolutions of the 14 CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) ANNOUNCEMENT ON THE RESOLUTIONS OF THE FOURTEENTH MEETING OF THE FIFTH SESSION OF THE BOARD OF DIRECTORS Proposal to Start the Restructuring of]

By info| 2016-03-23T08:48:47+00:00 February 20th, 2014|Categories: Chinese Stocks, SNP, Webplus ver|Tags: 0001123658, 2014-02-20, 2911, 6-K, PETROLEUM REFINING, SNP|0 Comments

LONG [eLong] 6-K: (Original Filing)

[Quarter and Full Year Unaudited Financial Results eLong Reports Fourth Net revenues surpassed RMB1 billion and hotel room nights exceeded 25 million in 2013 LONG BEIJING, February 19, 2014 /PRNewswire/ -- eLong, Inc. (Nasdaq: Highlights – Fourth Quarter 2013 n Hotel room nights stayed in the fourth quarter n Hotel commission revenue for the fourth quarter n Net revenues for] []

By info| 2016-03-28T10:06:41+00:00 February 20th, 2014|Categories: Chinese Stocks, LONG, SEC Original|Tags: 0001290903, 2014-02-20, 4700, 6-K, LONG, TRANSPORTATION SERVICES|0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year’s USD$21.8 million loss from operations XIANYANG, China, February 20, 2014 –Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 20, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By info| 2016-03-28T18:42:24+00:00 February 20th, 2014|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2014-02-20, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth

[Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year’s USD$21.8 million loss from operations XIANYANG, China, February 20, 2014 –Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 20, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By info| 2016-03-28T18:43:16+00:00 February 20th, 2014|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2014-02-20, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SFUN [SouFun] SC 13D/A: (Original Filing)

[SCHEDULE 13D/A (Amendment No. 7) SouFun Holdings Limited (Name of Issuer) Class A ordinary shares, par value HK$1.00 per share (Title of Class of Securities) 836034108** (CUSIP Number) Amit Gupta 6th Floor, Tower A 1 CyberCity, Ebene, Mauritius +230 (403) 6074 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) With a copy to: Thomas J.]

By info| 2016-03-30T17:00:46+00:00 February 20th, 2014|Categories: Chinese Stocks, SEC Original, SFUN|Tags: 0001294404, 2014-02-20, 7374, SC_13D.A, SERVICES-COMPUTER PROCESSING and DATA PREPARATION, SFUN|0 Comments

SFUN [SouFun] SC 13D/A: SCHEDULE 13D/A (Amendment No. 7) SouFun Holdings Limited

[SCHEDULE 13D/A (Amendment No. 7) SouFun Holdings Limited (Name of Issuer) Class A ordinary shares, par value HK$1.00 per share (Title of Class of Securities) 836034108** (CUSIP Number) Amit Gupta 6th Floor, Tower A 1 CyberCity, Ebene, Mauritius +230 (403) 6074 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) With a copy to: Thomas J.]

By info| 2016-03-30T17:01:42+00:00 February 20th, 2014|Categories: Chinese Stocks, SFUN, Webplus ver|Tags: 0001294404, 2014-02-20, 7374, SC_13D.A, SERVICES-COMPUTER PROCESSING and DATA PREPARATION, SFUN|0 Comments

JASO [JA Solar] 6-K: (Original Filing)

[CONFIDENTIAL 2014-02-18 FINAL [1] JA Solar Multi-Si Solar Cells Surpass 19% Conversion Efficiency Shanghai, China, February 18, 2014 - JA Solar Holdings Co., Ltd. (Nasdaq:JASO) (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar power products, today announced that its multi-crystalline silicon (multi-Si) solar cells have surpassed 19% conversion efficiency. This latest improvement in efficiency,] [JA Solar Holdings Co., Ltd. By Baofang Jin]

By info| 2016-03-30T21:42:28+00:00 February 20th, 2014|Categories: Chinese Stocks, JASO, SEC Original|Tags: 0001385598, 2014-02-20, 3674, 6-K, JASO, SEMICONDUCTORS and RELATED DEVICES|0 Comments

CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)

[1 CHINA UNICOM (HONG KONG) LIMITED]

By info| 2016-03-15T04:38:00+00:00 February 20th, 2014|Categories: Chinese Stocks, CHU, SEC Original|Tags: 0001113866, 2014-02-20, 4812, 6-K, CHU, RADIO TELEPHONE COMMUNICATIONS|0 Comments